Pain Management

Study examines patient-reported outcomes for opioid dependence treatment with weekly or monthly subcutaneous depot buprenorphine versus daily sublingual buprenorphine.

Terminally ill patients in hospice care are being prescribed fewer opioids, meaning they may not be getting adequate pain relief.

Analgesic has potential for problematic use, including tolerance, dependence and occasional fatalities.

Postherpetic neuralgia (PHN) is one of the few chronic pain conditions that we can often pre-emptively avoid.

Indivior launches new buprenorphine/naloxone film dosage form, adding to the original sublingual tablets.

Study shows medical cannabis use may help decrease the use of prescription medications including opioids, and may have a harm-reduction role in the opioid crisis.